Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class ASSE: 600513

Announcement on Obtaining Notice of Approval for Clinical Trials of Class 2 Improved New Drug

· Issued by Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Clinical Trials of Class 2 Improved New Drug

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis